Galunisertib enhances chimeric antigen receptor-modified T cell function
Chimeric antigen receptor (CAR) T cell therapy still faces the challenge of immunosuppression when treating solid tumors. TGF-β is one of the critical factors in the tumor microenvironment to help tumors escape surveillance by the immune system. Here we tried using the combination of a small molecul...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-06-01
|
Series: | European Journal of Histochemistry |
Subjects: | |
Online Access: | https://www.ejh.it/index.php/ejh/article/view/3122 |